3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Hodgkin Disease
11
Neoplasms
2
Mycosis Fungoides
2
Squamous Cell Carcinoma of Head and Neck
1
Sezary Syndrome
1
Mesothelioma, Malignant
1
Melanoma
1
Lymphomatoid Papulosis
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Cyclophosphamide
12
Vincristine
9
Etoposide
8
venetoclax
7
Methotrexate
6
Doxorubicin
6
Dexamethasone
6
Cytarabine
6
Prednisone
5
Calcium Dobesilate
5
prednylidene
4
pegaspargase
4
merphos
4
dexamethasone acetate
4
dexamethasone 21-phosphate
4
deltacortene
4
daratumumab
4
calaspargase pegol
4
auricularum
4
Specimen Handling
4
Granulocyte Colony-Stimulating Factor
4
fludarabine phosphate
3
Thioguanine
3
Rituximab
3
Peripheral Blood Stem Cell Transplantation
3
Mercaptopurine
3
Magnetic Resonance Spectroscopy
3
Leucovorin
3
Hydrocortisone
3
Filgrastim
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
×
Brentuximab Vedotin
×
90 days
×
Clear all
No trials found.